Amlan International to Showcase NeutraPath® Research and Calibrin® -Z Technical Demonstrations at International Production and Processing Expo (IPPE) 2025
Amlan International, a division of Oil-Dri of America (NYSE: ODC), will showcase its mineral-based animal health technologies at IPPE 2025 from January 28-30 in Atlanta. The company will highlight two key products: NeutraPath®, a natural pathogen control solution, and Calibrin®-Z, a biotoxin binder.
New research on NeutraPath's efficacy in broilers challenged with necrotic enteritis will be presented by Dr. Anthony Quant at the International Poultry Scientific Forum. Additionally, Dr. Gino Lorenzoni will present findings on feed additives' impact on broiler performance.
The company will conduct live demonstrations of Calibrin-Z's binding properties, led by Dr. Dongping Wang and Dr. Marc Herpfer, showcasing how the product binds mycotoxins and pathogens. These demonstrations will occur multiple times during the expo at Amlan's booth B4011.
Amlan International, una divisione di Oil-Dri of America (NYSE: ODC), presenterà le sue tecnologie per la salute animale a base minerale all'IPPE 2025, che si svolgerà dal 28 al 30 gennaio ad Atlanta. L'azienda metterà in evidenza due prodotti chiave: NeutraPath®, una soluzione naturale per il controllo dei patogeni, e Calibrin®-Z, un legante per le biotossine.
Il Dr. Anthony Quant presenterà nuove ricerche sull'efficacia di NeutraPath nei polli broiler affetti da enterite necrotizzante durante il Forum Scientifico Internazionale del Pollame. Inoltre, il Dr. Gino Lorenzoni presenterà risultati sull'impatto degli additivi per mangimi sulle prestazioni dei broiler.
L'azienda condurrà dimostrazioni dal vivo delle proprietà di legame di Calibrin-Z, guidate dal Dr. Dongping Wang e dal Dr. Marc Herpfer, mostrando come il prodotto lega le micotossine e i patogeni. Queste dimostrazioni si svolgeranno più volte durante l'esposizione presso lo stand B4011 di Amlan.
Amlan International, una división de Oil-Dri of America (NYSE: ODC), presentará sus tecnologías de salud animal a base de minerales en el IPPE 2025, que tendrá lugar del 28 al 30 de enero en Atlanta. La compañía destacará dos productos clave: NeutraPath®, una solución natural para el control de patógenos, y Calibrin®-Z, un aglutinante de biotoxinas.
El Dr. Anthony Quant presentará nuevas investigaciones sobre la eficacia de NeutraPath en pollos broiler desafiados con enteritis necrótica en el Foro Científico Internacional de Aves. Además, el Dr. Gino Lorenzoni presentará hallazgos sobre el impacto de los aditivos en el rendimiento de los broilers.
La empresa realizará demostraciones en vivo de las propiedades de enlace de Calibrin-Z, dirigidas por el Dr. Dongping Wang y el Dr. Marc Herpfer, mostrando cómo el producto se une a micotoxinas y patógenos. Estas demostraciones se llevarán a cabo varias veces durante la exposición en el stand B4011 de Amlan.
Amlan International는 Oil-Dri of America (NYSE: ODC)의 한 부문으로서, 1월 28일부터 30일까지 애틀랜타에서 열리는 IPPE 2025에서 광물 기반 동물 건강 기술을 선보여요. 이 회사는 두 가지 핵심 제품인 NeutraPath® (자연적 병 원인 통제 솔루션)과 Calibrin®-Z (바이오독소 결합제)를 강조할 것입니다.
안소니 콴트 박사는 국재가금 과학 포럼에서 괴사성 장염에 도전받은 브로일러에서 NeutraPath의 효능에 대한 새로운 연구 결과를 발표할 것입니다. 또한 지노 로렌조니 박사는 사료 첨가물이 브로일러 성능에 미치는 영향에 대한 연구 결과를 발표할 것입니다.
이 회사는 Dongping Wang 박사와 Marc Herpfer 박사가 이끄는 Calibrin-Z의 결합 특성에 대한 실시간 시연을 진행하여 이 제품이 마이코톡신 및 병원균과 결합하는 방법을 보여줄 것입니다. 이러한 시연은 Amlan의 B4011 부스에서 박람회 기간 중 여러 차례 진행될 예정입니다.
Amlan International, une division de Oil-Dri of America (NYSE: ODC), présentera ses technologies de santé animale à base minérale lors de IPPE 2025, qui se tiendra du 28 au 30 janvier à Atlanta. L'entreprise mettra en avant deux produits phares : NeutraPath®, une solution naturelle de contrôle des pathogènes, et Calibrin®-Z, un liant pour mycotoxines.
Le Dr. Anthony Quant présentera de nouvelles recherches sur l'efficacité de NeutraPath chez des poulets de chair confrontés à une entérite nécrosante lors du Forum International Scientifique de la Volaille. De plus, le Dr. Gino Lorenzoni présentera des résultats sur l'impact des additifs alimentaires sur les performances des poulets.
L'entreprise réalisera des démonstrations en direct des propriétés de liaison de Calibrin-Z, dirigées par le Dr. Dongping Wang et le Dr. Marc Herpfer, montrant comment le produit lie les mycotoxines et les pathogènes. Ces démonstrations auront lieu plusieurs fois au cours de l'exposition au stand B4011 d'Amlan.
Amlan International, eine Division von Oil-Dri of America (NYSE: ODC), wird ihre mineralbasierten Tiergesundheitstechnologien auf der IPPE 2025 vom 28. bis 30. Januar in Atlanta vorstellen. Das Unternehmen wird zwei Schlüsselprodukte hervorheben: NeutraPath®, eine natürliche Lösung zur Kontrolle von Krankheitserregern, und Calibrin®-Z, einen Biotoxinbinder.
Dr. Anthony Quant wird beim Internationalen Geflügelwissenschaftsforum neue Forschungen zur Wirksamkeit von NeutraPath bei Broilern, die mit nekrotisierender Enteritis konfrontiert sind, präsentieren. Darüber hinaus wird Dr. Gino Lorenzoni Ergebnisse zur Wirkung von Futtermitteln auf die Leistung von Broilern vorstellen.
Das Unternehmen wird Live-Demonstrationen der Bindungseigenschaften von Calibrin-Z durchführen, die von Dr. Dongping Wang und Dr. Marc Herpfer geleitet werden und zeigen, wie das Produkt Mykotoxine und Krankheitserreger bindet. Diese Demonstrationen finden während der Messe mehrmals am Stand B4011 von Amlan statt.
- Company to present new research demonstrating NeutraPath's effectiveness in treating necrotic enteritis in broilers
- Live demonstrations planned to showcase Calibrin-Z's binding capabilities for mycotoxins and pathogens
- None.
CHICAGO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Amlan® International, a leading provider of mineral-based technologies for animal health, will be exhibiting at the International Production & Processing Expo (IPPE) 2025, held January 28–30, 2025, at the Georgia World Congress Center in Atlanta, Georgia. Amlan’s booth, B4011, will feature cutting-edge feed additives aimed at enhancing poultry health and productivity, with live-streamed demonstrations of the binding power and unique mineral properties of Amlan’s mineral technology.
NeutraPath®, Amlan’s breakthrough natural pathogen control solution available in select international markets, will be prominently featured at the expo with an oral presentation of new research. This innovative feed additive combines essential oils, fatty acids, and Amlan's proprietary mineral technology to neutralize pathogenic bacteria, improve intestinal health, and provide poultry producers with a natural, effective alternative for pathogen control.
Dr. Anthony Quant, Ph.D., Senior Poultry Nutritionist at Kalmbach Nutritional Services, will present research at the International Poultry Scientific Forum (IPSF), showcasing NeutraPath's efficacy as a feed additive for broilers challenged with necrotic enteritis. This presentation will highlight the beneficial performance impacts of NeutraPath when used to counter one of the most prevalent challenges poultry producers face globally.
The oral abstract: T83, Evaluating the Effect of Dietary Supplementation of NeutraPath® and Tribasic Copper Chloride on the Growth Performance of Ross 308 Broilers Exposed to a Necrotic Enteritis Challenge, will be presented on January 28, 2025, at 8:30 a.m. EST, room B406.
In addition, Amlan will sponsor the presentation of new research on the impact of feed additives on broiler performance when exposed to a necrotic enteritis challenge at an upcoming educational TECHTalk. The oral presentation, titled, "Enhancing Broiler Productivity: Nutritional Programs to Safeguard Intestinal Health from Common Pathogens," will be delivered by Dr. Gino Lorenzoni, Associate Professor of Poultry Science and Avian Health at Penn State University. The presentation will take place on January 28th, 2025, at 12:00 p.m. EST, in Theatre B.
“We’re excited to share our latest studies and highlight how our innovative solutions are advancing poultry gut health,” said Dr. Wade Robey, President of Amlan International. “NeutraPath goes beyond traditional pathogen binding — it actively disrupts bacterial membrane integrity, delivering powerful support for optimal performance, even in challenging environments.”
Live Demonstrations of Calibrin-Z's Rapid Binding Effects and Unique Mineral Properties
Amlan will also host two live streamed demonstrations of its broad-spectrum biotoxin binder, Calibrin-Z, during exhibit hall hours at the upcoming event. Attendees are invited to visit the Amlan booth (B4011) for an in-depth look at Calibrin-Z’s speed and binding efficacy. First, Dr. Dongping Wang, Senior Research Scientist at Oil-Dri Corporation of America, will lead the demonstrations on showcasing how Calibrin-Z quickly and effectively binds mycotoxins and pathogens, neutralizing their harmful effects on poultry health and performance. Second, Dr. Marc Herpfer, VP of New Technologies, will explain the importance of high-quality mineral technologies in poultry health. The presentation, titled "Not All Bentonites Are Created Equal," will showcase how subtle differences in the physical properties of Amlan's minerals can help provide a competitive edge in poultry performance.
The live demonstrations will take place on Tuesday, January 28, 2025, at 10:00 a.m. EST and 2:00 p.m. EST, and Wednesday, January 29, 2025, at 10:00 a.m. EST and 2:00 p.m. EST. Dr. Herpfer will be onsite to speak with attendees and further elaborate on Amlan’s mineral solution technology.
“Amlan is committed to fostering collaboration and advancing innovation within the industry,” says Mrs. Reagan Culbertson, Vice President of Strategic Marketing. “We encourage expo attendees, media professionals, and fellow exhibitors to visit booth B4011 to see how Amlan is helping producers drive profits naturally with superior mineral technology.”
For more information on Amlan International, please visit amlan.com.
Company Information
Amlan is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Leveraging over 80 years of expertise in mineral science, Oil-Dri Corporation of America, doing business as “Amlan International,” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives worldwide. Product availability may vary by country, associated claims do not constitute medical claims and may differ based on government requirements.
Contact:
Reagan Culbertson, Vice President of Strategic Marketing, B2B
Reagan.culbertson@amlan.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/66aa0146-7a0e-47fc-a02b-5bc16f87c2ba
FAQ
What new research will be presented about NeutraPath at IPPE 2025?
When and where will Calibrin-Z demonstrations take place at IPPE 2025?
What are the key products ODC's Amlan International is showcasing at IPPE 2025?
How does NeutraPath work to improve poultry health?
